Inhalation Drug Delivery Flashcards Preview

Pharmaceutics > Inhalation Drug Delivery > Flashcards

Flashcards in Inhalation Drug Delivery Deck (39)
Loading flashcards...
1

What are the benefits of inhalation drug delivery?

- rapid onset of action - good for breakthrough pain
- avoids GI degradation - good for compounds that are prone to this
- avoids first pass metabolism
- can use a lower dose of the drug, meaning fewer/less risk of ADR
- accurate dose adjustment and titration, good for when required dosing
- use of small volumes (25mL - 100mL)
- good to avoid physical/chemical interactions
- good for when a drug has issues orally with it's pharmacokinetics (unpredictable/inconsistent)

2

What parts of the airway consists of the upper respiratory tract?

- buccal
- sublingual
- nasal cavities (this warms and moistens the air an filters out large particles)
- pharynx
- larynx
- epiglottis

3

What parts of the airway consist of the lower respiratory tract?

- trachea
- bronchi (primary and secondary)
- bronchioles
- alveoli

4

What is the diameter of the trachea?

1.5cm - 2cm

5

What is the diameter of the bronchioles?

< 1 mm

6

What is the diameter and surface area of the alveoli?

< 0.5 mm

have 30 million alveoli per lung, giving a 70cm2 surface area for gas exchange

7

What is particle deposition affected by?

- product characteristics
- anatomical and physiological characteristics

8

What product characteristics affects particle deposition?

Dry Powder (particles)
- diameter, shape, density, charge, surface chemistry

Liquid Aerosol (liquid droplets)
- droplet size, velocity, nature of propellant

9

What anatomical and physiological characteristics affect particle deposition?

- lung capacity
- lung geometry
- breathing pattern (frequency + tidal volume )
- disease/pathology

10

What particle size-related effects are there when considering particle deposition?

- inertial impaction
- gravitational sedimentation
- brownian diffusion
- electrostatic attractions
- interception

11

What is inertial impaction?

- related to bigger sized particles (above 1um - micron in size)
- momentum of the particle means that it doesn't follow the airflow and instead impacts on the wall
- bigger particles move faster

12

What is gravitational sedimentation?

- this is where particles sediment in the gap between breathing in and breathing out
- related to the residence time in an airway and terminal settling velocity
- also related to bigger sized particles

this is increased when someone holds their breath

13

What is brownian diffusion?

- related to smaller particles (below sub micron sized < 0.1 um)
- random collision of a particle with the airway wall

14

What is electrostatic attraction?

- where the charge on the particle induces a charge on the airway wall
- this happens further down the airways as particles have to be close to the wall in order to induce a charge

15

What is interception?

- where the particle size approaches the same diameter as the airways and deposit through interception
- this is not significant for spherical shaped particles

16

What types of particles are impaction and sedimentation relevant to?

- larger particles over 1um in size
- effect of the process is PROPORTIONAL to the size of the particle
- the bigger the particle, the bigger the effect of the process on particle deposition

17

What types of particles is diffusion relevant to?

- smaller particles that are sub micron size, less than 0.1um
- effect of the process is INVERSELY proportional to the size of the particle
- the smaller the particle, the bigger the effect of the process on particle deposition

18

What different types of inhalation devices are available?

- sprays (useful for the Upper Respiratory Tract)
- pDMIs (uses solvent propellents, used to be CFCs and is now HFAs)
- Superfine Particle Inhalers (developed for small airways disease, uses HFA to produce very small particles)
- Nebulisers (mostly used in hospitals, the drug is dispersed in a polar solvent, usually water)
- Dry Powder Inhalers (these are replacing pDMIs as they do not use a solvent propellant at all, the powder fluidises as the patient inhales and the drug shears from larger particles so that it can penetrate deeper in the lungs)

19

What deposition is achieved with traditional delivery devices?

these formulations produce particle sizes of <10 um, between 2 and 8um
- this means that deposition is primarily achieved through impaction and sedimentation

80 - 90% of the dose is lost and NOT deposited, lots of GI absorption leading to side effects

newer devices produce smaller particles that travel at a lower velocity, so that you get over 30 % deposition

20

Nasal Sprays - Upper Respiratory Tract

- metered dose pumps, actuator released causes the dip tube to fill with formulation for next dose
- VIANASE, controlled particle dispersion (10-30um) to minimise GI and Pulmonary deposition so that it only goes to the nose
- OPTINOSE, bidirectional flow (when a patient blows out, soft pallet closes and shuts the nasal cavity from the throat to prevent any deposition elsewhere)

21

pressurised Metered Dose Inhalers (pMDIs) - Lower Respiratory Tract

- uses a liquid propellant (HFA)
- generates fast moving micro-fine suspensions
- slow and deep inhalation
- valve and inhalation at the same time
(manually/breath-actuated/battery-activated)
- dose counters incorporated

22

What are the excipients of a pDMI?

- co-solvent/inverse micelles/liposomes to enhance solubility of surfactants
- surfactants to adsorb particles and prevent agglomeration (shake before use)
- menthol for flavouring
- ascorbic acid as an antioxidant
- phenyl ethanol for an antimicrobial preservative

23

MDI Case Study: 20um particles

- larger particles likely to deposit in the UPPER airways by impaction and sedimentation (if the flow rate is low)
- large particles, big mass, so will deposit and not a lot will be exhaled
- upper airways are ciliated, meaning that drug deposited here will be moved up to be swallowed meaning there will be drug absorption in the GI tract

24

MDI Case Study: 6um - 2um particles

- these particles are smaller in size and will have less momentum, so will not impact in the upper airways as it is less branched, more likely to further down
- a larger amount of the 6um will be deposited than the 2um as the particles are bigger and less likely to be affected by the air flow
- these particles are too large to be influenced by Brownian diffusion

25

MDI Case Study: 0.6um particles

- small particle, with low mass and momentum
- will not deposit through impaction or sedimentation as the mass is too low
- some MAY deposit through brownian diffusion, but this effect is only really seen with particles that are sub-micron size
- no mechanisms of deposition means that the particle will be exhaled

26

What has now taken over the MDIs since the ban of CFCs?

SUPERFINE PARTICLE INHALERS

27

What are superfine particle inhalers used for?

small airways disease (asthma/COPD)
these are inadequately treated with traditional inhalers:
- larger particles produced deposit in the upper airway through impaction and sedimentation
- the smaller particles produced do not deposit at all, as they are too small to deposit through impaction and sedimentation but not small enough to be affected by Brownian diffusion

28

What size particles do superfine particle inhalers produce?

extrafine (less than 1um)
ultrafine (less than 100nm)

29

What are the benefits of superfine particle inhalers?

- allows for a reduction in the daily dose of inhaled corticosteroids, giving better management and quality of life
- the superfine particles when formulated with HFA instead of CFC lead to improved treatment

30

Nebulisers

- used at home and in hospitals that suffer with conditions that are unable to be treated with other inhalers
- inefficient and only deliver 13% of the nebuliser drug
- BUT allow for administration of higher doses